Literature DB >> 2563135

Hypothyroidism and goitre during interleukin-2 therapy without LAK cells.

P A van Liessum, P H de Mulder, E J Mattijssen, F H Corstens, D J Wagener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563135     DOI： 10.1016/s0140-6736(89)91244-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Hypothyroidism and goiter during interleukin-2 therapy.

Authors:  P Berthaud; M Schlumberger; E Comoy; M F Avril; T Le Chevalier; M Spielmann; T Tursz
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 2.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

3.  Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.

Authors:  H Gisslinger; B Gilly; W Woloszczuk; W R Mayr; L Havelec; W Linkesch; M Weissel
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 4.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

5.  Pure Red Cell Aplasia Following Interleukin-2 Therapy.

Authors:  Janice P Dutcher; Wen Fan; Peter H Wiernik
Journal:  J Investig Med High Impact Case Rep       Date:  2016-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.